Interleukin 10 (IL10) proximal promoter polymorphisms beyond clinical response in classical Hodgkin lymphoma: Exploring the basis for the genetic control of the tumor microenvironment

References

• Iyer SS, Cheng G. Role of interleukin 10 transcriptional regulation in inflammation and autoimmune disease. Crit Rev Immunol. 2012;32:23–63. doi:10.1615/CritRevImmunol.v32.i1.30. PMID:22428854.
   PubMed Web of Science ®Google Scholar
• Burdin N, Rousset F, Banchereau J. B-cell-derived IL-10: production and function. Methods San Diego Calif. 1997;11:98–111. doi:10.1006/meth.1996.0393.
   PubMed Web of Science ®Google Scholar
• Saraiva M, O'Garra A. The regulation of IL-10 production by immune cells. Nat Rev Immunol. 2010;10:170–81. doi:10.1038/nri2711. PMID:20154735.
   PubMed Web of Science ®Google Scholar
• Ng THS, Britton GJ, Hill EV, Verhagen J, Burton BR, Wraith DC. Regulation of Adaptive Immunity; The Role of Interleukin-10. Front Immunol [Internet] 2013 [cited 2014 Mar 24]; 4. Available from: http://www.frontiersin.org/Journal/10.3389/fimmu.2013.00129/full. doi:10.3389/fimmu.2013.00129.
   PubMed Web of Science ®Google Scholar
• Couper KN, Blount DG, Riley EM. IL-10: the master regulator of immunity to infection. J Immunol Baltim Md 1950. 2008;180:5771–7.
   Google Scholar
• Biswas SK, Allavena P, Mantovani A. Tumor-associated macrophages: functional diversity, clinical significance, and open questions. Semin Immunopathol. 2013;35:585–600. doi:10.1007/s00281-013-0367-7. PMID:23657835.
   PubMed Web of Science ®Google Scholar
• Reuss E, Fimmers R, Kruger A, Becker C, Rittner C, Höhler T. Differential regulation of interleukin-10 production by genetic and environmental factors–a twin study. Genes Immun. 2002;3:407–13. doi:10.1038/sj.gene.6363920. PMID:12424622.
   PubMed Web of Science ®Google Scholar
• Eskdale J, Gallagher G, Verweij CL, Keijsers V, Westendorp RG, Huizinga TW. Interleukin 10 secretion in relation to human IL-10 locus haplotypes. Proc Natl Acad Sci U S A. 1998;95:9465–70. doi:10.1073/pnas.95.16.9465. PMID:9689103.
   PubMed Web of Science ®Google Scholar
• Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenetics Off J Br Soc Histocompat Immunogenetics. 1997;24:1–8. doi:10.1111/j.1365-2370.1997.tb00001.x.
   PubMedGoogle Scholar
• Kube D, Rieth H, Eskdale J, Kremsner PG, Gallagher G. Structural characterisation of the distal 5′ flanking region of the human interleukin-10 gene. Genes Immun. 2001;2:181–90. doi:10.1038/sj.gene.6363750. PMID:11477472.
   PubMed Web of Science ®Google Scholar
• Rieth H, Mörmann M, Luty AJF, Assohou-Luty CA, Roupelieva M, Kremsner PG, Kube D. A three base pair gene variation within the distal 5′-flanking region of the interleukin-10 (IL-10) gene is related to the in vitro IL-10 production capacity of lipopolysaccharide-stimulated peripheral blood mononuclear cells. Eur Cytokine Netw. 2004;15:153–8. PMID:15319176.
   PubMed Web of Science ®Google Scholar
• Kurreeman FAS. Transcription of the IL10 gene reveals allele-specific regulation at the mRNA level. Hum Mol Genet. 2004;13:1755–62. doi:10.1093/hmg/ddh187. PMID:15198994.
   PubMed Web of Science ®Google Scholar
• Mörmann M, Rieth H, Hua TD, Assohou C, Roupelieva M, Hu SL, Kremsner PG, Luty AJF, Kube D. Mosaics of gene variations in the Interleukin-10 gene promoter affect interleukin-10 production depending on the stimulation used. Genes Immun. 2004;5:246–55. doi:10.1038/sj.gene.6364073. PMID:15116066.
   PubMed Web of Science ®Google Scholar
• Larsson L, Rymo L, Berglundh T. Sp1 binds to the G allele of the- 1087 polymorphism in the IL-10 promoter and promotes IL-10 mRNA transcription and protein production. Genes Immun. 2010;11:181–7. doi:10.1038/gene.2009.103. PMID:20072143.
   PubMed Web of Science ®Google Scholar
• Khatri VP, Caligiuri MA. A review of the association between interleukin-10 and human B-cell malignancies. Cancer Immunol Immunother CII. 1998;46:239–44. doi:10.1007/s002620050483. PMID:9690451.
   PubMed Web of Science ®Google Scholar
• Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol. 2001;19:683–765. doi:10.1146/annurev.immunol.19.1.683. PMID:11244051.
   PubMed Web of Science ®Google Scholar
• Küppers R. The biology of Hodgkin's lymphoma. Nat Rev Cancer. 2009;9:15–27. doi:10.1038/nrc2542. PMID:19078975.
   PubMed Web of Science ®Google Scholar
• Steidl C, Connors JM, Gascoyne RD. Molecular pathogenesis of Hodgkin's lymphoma: increasing evidence of the importance of the microenvironment. J Clin Oncol Off J Am Soc Clin Oncol. 2011;29:1812–26. doi:10.1200/JCO.2010.32.8401.
   PubMed Web of Science ®Google Scholar
• Blay JY, Burdin N, Rousset F, Lenoir G, Biron P, Philip T, Banchereau J, Favrot MC. Serum interleukin-10 in non-Hodgkin's lymphoma: a prognostic factor. Blood. 1993;82:2169–74. PMID:8400266.
   PubMed Web of Science ®Google Scholar
• Bohlen H, Kessler M, Sextro M, Diehl V, Tesch H. Poor clinical outcome of patients with Hodgkin's disease and elevated interleukin-10 serum levels. Clinical significance of interleukin-10 serum levels for Hodgkin's disease. Ann Hematol. 2000;79:110–3. doi:10.1007/s002770050564. PMID:10803931.
   PubMed Web of Science ®Google Scholar
• Viviani S, Notti P, Bonfante V, Verderio P, Valagussa P, Bonadonna G. Elevated pretreatment serum levels of Il-10 are associated with a poor prognosis in Hodgkin's disease, the milan cancer institute experience. Med Oncol Northwood Lond Engl. 2000;17:59–63. doi:10.1007/BF02826218.
   PubMed Web of Science ®Google Scholar
• Vassilakopoulos TP, Nadali G, Angelopoulou MK, Siakantaris MP, Dimopoulou MN, Kontopidou FN, Rassidakis GZ, Doussis-Anagnostopoulou IA, Hatzioannou M, Vaiopoulos G, et al. Serum interleukin-10 levels are an independent prognostic factor for patients with Hodgkin's lymphoma. Haematologica. 2001;86:274–81. PMID:11255274.
   PubMed Web of Science ®Google Scholar
• Rautert R, Schinköthe T, Franklin J, Weihrauch M, Boll B, Pogge E, Bredenfeld H, Engert A, Diehl V, Re D. Elevated pretreatment interleukin-10 serum level is an International Prognostic Score (IPS)-independent risk factor for early treatment failure in advanced stage Hodgkin lymphoma. Leuk Lymphoma. 2008;49:2091–8. doi:10.1080/10428190802441339. PMID:19021051.
   PubMed Web of Science ®Google Scholar
• Hohaus S, Giachelia M, Massini G, Vannata B, Criscuolo M, Martini M, D'Alo' F, Voso MT, Larocca LM, Leone G. Clinical significance of interleukin-10 gene polymorphisms and plasma levels in Hodgkin lymphoma. Leuk Res. 2009;33:1352–6. doi:10.1016/j.leukres.2009.01.009. PMID:19201467.
   PubMed Web of Science ®Google Scholar
• Hohaus S, Giachelia M, Di Febo A, Martini M, Massini G, Vannata B, D'Alo' F, Guidi F, Greco M, Pierconti F, et al. Polymorphism in cytokine genes as prognostic markers in Hodgkin's lymphoma. Ann Oncol. 2007;18:1376–81. doi:10.1093/annonc/mdm132. PMID:17496310.
   PubMed Web of Science ®Google Scholar
• Schoof N, Franklin J, Furst R, Zander T, von Bonin F, Peyrade F, Trumper L, Diehl V, Engert A, Kube D, et al. Interleukin-10 Gene Polymorphisms are Associated With Freedom From Treatment Failure for Patients With Hodgkin Lymphoma. The Oncologist. 2013;18:80–9. doi:10.1634/theoncologist.2012-0291. PMID:23299779.
   PubMed Web of Science ®Google Scholar
• Yri OE, Ekstrøm PO, Hilden V, Gaudernack G, Liestøl K, Smeland EB, Holte H. Polymorphisms in genes encoding interleukin-10 and drug metabolizing enzymes GSTP1, GSTT1, GSTA1 and UGT1A1 influence risk and outcome in Hodgkin lymphoma. Leuk Lymphoma. 2012;53:1934–44. doi:10.3109/10428194.2012.682307. PMID:22475179.
   PubMed Web of Science ®Google Scholar
• Ghesquières H, Maurer MJ, Casasnovas O, Ansell SM, Larrabee BR, Lech-Maranda E, Novak AJ, Borrel A-L, Slager SL, Brice P, et al. Cytokine gene polymorphisms and progression-free survival in classical Hodgkin lymphoma by EBV status: results from two independent cohorts. Cytokine. 2013;64:523–31. doi:10.1016/j.cyto.2013.08.002. PMID:24008079.
   PubMed Web of Science ®Google Scholar
• Barros MHM, Vera-Lozada G, Soares FA, Niedobitek G, Hassan R. Tumor microenvironment composition in pediatric classical Hodgkin lymphoma is modulated by age and Epstein-Barr virus infection. Int J Cancer. 2012;131:1142–52. doi:10.1002/ijc.27314. PMID:22025264.
   PubMed Web of Science ®Google Scholar
• Eskdale J, Kube D, Gallagher G. A second polymorphic dinucleotide repeat in the 5′ flanking region of the human IL10 gene. Immunogenetics. 1996;45:82–3. doi:10.1007/s002510050174. PMID:8881045.
   PubMed Web of Science ®Google Scholar
• Barros MHM, Segges P, Vera-Lozada G, Hassan R, Niedobitek G. Macrophage Polarization Reflects T Cell Composition of Tumor Microenvironment in Pediatric Classical Hodgkin Lymphoma and Has Impact on Survival. PLOS ONE. 2015;10:e0124531. doi:10.1371/journal.pone.0124531. PMID:25978381.
   PubMed Web of Science ®Google Scholar
• Cao S, Liu J, Song L, Ma X. The protooncogene c-Maf is an essential transcription factor for IL-10 gene expression in macrophages. J Immunol. 2005;174:3484–92. doi:10.4049/jimmunol.174.6.3484. PMID:15749884.
   PubMed Web of Science ®Google Scholar
• Xu J, Yang Y, Qiu G, Lal G, Wu Z, Levy DE, Ochando JC, Bromberg JS, Ding Y. c-Maf Regulates IL-10 Expression during Th17 Polarization. J Immunol. 2009;182:6226–36. doi:10.4049/jimmunol.0900123. PMID:19414776.
   PubMed Web of Science ®Google Scholar
• Skinnider BF, Mak TW. The role of cytokines in classical Hodgkin lymphoma. Blood. 2002;99:4283–97. doi:10.1182/blood-2002-01-0099. PMID:12036854.
   PubMed Web of Science ®Google Scholar
• Aldinucci D, Gloghini A, Pinto A, De Filippi R, Carbone A. The classical Hodgkin's lymphoma microenvironment and its role in promoting tumour growth and immune escape. J Pathol. 2010;221:248–63. doi:10.1002/path.2711. PMID:20527019.
   PubMed Web of Science ®Google Scholar
• Gaiolla RD, Domingues MAC, Niéro-Melo L, de Oliveira DE. Serum levels of interleukins 6, 10, and 13 before and after treatment of classic Hodgkin lymphoma. Arch Pathol Lab Med. 2011;135:483–9. PMID:21466366.
   PubMed Web of Science ®Google Scholar
• Eskdale J, Keijsers V, Huizinga T, Gallagher G. Microsatellite alleles and single nucleotide polymorphisms (SNP) combine to form four major haplotype families at the human interleukin-10 (IL-10) locus. Genes Immun. 1999;1:151–5. doi:10.1038/sj.gene.6363656. PMID:11196662.
   PubMed Web of Science ®Google Scholar
• Huizinga TW, Keijsers V, Yanni G, Hall M, Ramage W, Lanchbury J, Pitzalis C, Drossaers-Bakker WK, Westendorp RG, Breedveld FC, et al. Are differences in interleukin 10 production associated with joint damage? Rheumatology. 2000;39:1180–8. doi:10.1093/rheumatology/39.11.1180. PMID:11085795.
   PubMed Web of Science ®Google Scholar
• Warlé MC, Farhan A, Metselaar HJ, Hop WC, Perrey C, Zondervan PE, Kap M, Kwekkeboom J, Ijzermans JN, Tilanus HW, et al. Are cytokine gene polymorphisms related to in vitro cytokine production profiles? Liver Transpl. 2003;9:170–81. doi:10.1053/jlts.2002.50014. PMID:12548511.
   PubMed Web of Science ®Google Scholar
• Helminen ME, Kilpinen S, Virta M, Hurme M. Susceptibility to primary Epstein-Barr virus infection is associated with interleukin-10 gene promoter polymorphism. J Infect Dis. 2001;184:777–80. doi:10.1086/322987. PMID:11517440.
   PubMed Web of Science ®Google Scholar
• Yang Y, Ochando J, Yopp A, Bromberg JS, Ding Y. IL-6 plays a unique role in initiating c-Maf expression during early stage of CD4T cell activation. J Immunol Baltim Md 1950. 2005;174:2720–9.
   Google Scholar
• Xiu B, Lin Y, Grote DM, Ziesmer SC, Gustafson MP, Maas ML, Zhang Z, Dietz AB, Porrata LF, Novak AJ, et al. IL-10 induces the development of immunosuppressive CD14(+)HLA-DR(low/−) monocytes in B-cell non-Hodgkin lymphoma. Blood Cancer J. 2015;5:e328. doi:10.1038/bcj.2015.56. PMID:26230952.
   PubMed Web of Science ®Google Scholar
• Kidd P. Th1/Th2 balance: the hypothesis, its limitations, and implications for health and disease. Altern Med Rev. 2003;8:223–46. PMID:12946237.
   PubMedGoogle Scholar
• Skapenko A, Niedobitek GU, Kalden JR, Lipsky PE, Schulze-Koops H. Generation and regulation of human Th1-biased immune responses in vivo: a critical role for IL-4 and IL-10. J Immunol Baltim Md 1950. 2004;172:6427–34.
   Google Scholar
• Steidl C, Lee T, Shah SP, Farinha P, Han G, Nayar T, Delaney A, Jones SJ, Iqbal J, Weisenburger DD. Tumor-associated macrophages and survival in classic Hodgkin's lymphoma. N Engl J Med. 2010;362:875–85. doi:10.1056/NEJMoa0905680. PMID:20220182.
   PubMed Web of Science ®Google Scholar
• Tzankov A, Matter MS, Dirnhofer S. Refined Prognostic Role of CD68-Positive Tumor Macrophages in the Context of the Cellular Micromilieu of Classical Hodgkin Lymphoma. Pathobiology. 2010;77:301–8. doi:10.1159/000321567. PMID:21266828.
   PubMed Web of Science ®Google Scholar
• Kamper P, Bendix K, Hamilton-Dutoit S, Honore B, Nyengaard JR, d'Amore F. Tumor-infiltrating macrophages correlate with adverse prognosis and Epstein-Barr virus status in classical Hodgkin's lymphoma. Haematologica. 2011;96:269–76. doi:10.3324/haematol.2010.031542. PMID:21071500.
   PubMed Web of Science ®Google Scholar
• Azambuja D, Natkunam Y, Biasoli I, Lossos IS, Anderson MW, Morais JC, Spector N. Lack of association of tumor-associated macrophages with clinical outcome in patients with classical Hodgkin's lymphoma. Ann Oncol. 2012;23:736–42. doi:10.1093/annonc/mdr157. PMID:21602260.
   PubMed Web of Science ®Google Scholar
• Cencini E, Fabbri A, Rigacci L, Lazzi S, Gini G, Cox MC, Mancuso S, Abruzzese E, Kovalchuk S, Goteri G, et al. Evaluation of the prognostic role of tumour-associated macrophages in newly diagnosed classical Hodgkin lymphoma and correlation with early FDG-PET assessment. Hematol Oncol. 2017;35:69–78. doi:10.1002/hon.2249. PMID:26251194.
   PubMed Web of Science ®Google Scholar
• Steidl C, Farinha P, Gascoyne RD. Macrophages predict treatment outcome in Hodgkin's lymphoma. Haematologica. 2011;96:186–9. doi:10.3324/haematol.2010.033316. PMID:21282720.
   PubMed Web of Science ®Google Scholar
• Ruella M, Klichinsky M, Kenderian SS, Shestova O, Ziober A, Kraft DO, Feldman M, Wasik MA, June CH, Gill S. Overcoming the Immunosuppressive Tumor Microenvironment of Hodgkin Lymphoma Using Chimeric Antigen Receptor T Cells. Cancer Discov. 2017; 7:1154–67. doi:10.1158/2159-8290.CD-16-0850.
   PubMed Web of Science ®Google Scholar
• Herbst H, Foss HD, Samol J, Araujo I, Klotzbach H, Krause H, Agathanggelou A, Niedobitek G, Stein H. Frequent expression of interleukin-10 by Epstein-Barr virus-harboring tumor cells of Hodgkin's disease. Blood. 1996;87:2918–29. PMID:8639912.
   PubMed Web of Science ®Google Scholar
• Morales O, Mrizak D, François V, Mustapha R, Miroux C, Depil S, Decouvelaere A-V, Lionne-Huyghe P, Auriault C, de Launoit Y, et al. Epstein-Barr virus infection induces an increase of T regulatory type 1 cells in Hodgkin lymphoma patients. Br J Haematol. 2014;166:875–90. doi:10.1111/bjh.12980. PMID:25041527.
   PubMed Web of Science ®Google Scholar
• Chapman AL, Rickinson AB, Thomas WA, Jarrett RF, Crocker J, Lee SP. Epstein-Barr virus-specific cytotoxic T lymphocyte responses in the blood and tumor site of Hodgkin's disease patients: implications for a T-cell-based therapy. Cancer Res. 2001;61:6219–26. PMID:11507075.
   PubMed Web of Science ®Google Scholar
• Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW, editors. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon, France: IARC Press; 2008.
   Google Scholar
• Barros MHM, Hassan R, Niedobitek G. Disease patterns in pediatric classical Hodgkin lymphoma: a report from a developing area in Brazil. Hematol Oncol. 2011;29:190–5. doi:10.1002/hon.984. PMID:21374695.
   PubMed Web of Science ®Google Scholar
• Vera-Lozada G, Scholl V, Barros MHM, Sisti D, Guescini M, Stocchi V, Stefanoff CG, Hassan R. Analysis of biological and technical variability in gene expression assays from formalin-fixed paraffin-embedded classical Hodgkin lymphomas. Exp Mol Pathol. 2014;97:433–9. doi:10.1016/j.yexmp.2014.09.014. PMID:25236575.
   PubMed Web of Science ®Google Scholar
• Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc. 2008;3:1101–8. doi:10.1038/nprot.2008.73. PMID:18546601.
   PubMed Web of Science ®Google Scholar
• Barros MHM, Hauck F, Dreyer JH, Kempkes B, Niedobitek G. Macrophage polarisation: an immunohistochemical approach for identifying M1 and M2 macrophages. PloS One. 2013;8:e80908. doi:10.1371/journal.pone.0080908. PMID:24260507.
   PubMed Web of Science ®Google Scholar
• Fiorentino DF, Bond MW, Mosmann TR. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med. 1989;170:2081–95. doi:10.1084/jem.170.6.2081. PMID:2531194.
   PubMed Web of Science ®Google Scholar